Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The FDA has never approved IGF-1 LR3 as a drug, and the Federal Trade Commission treats its sale for bodybuilding or anti-aging purposes as a violation of labeling and marketing laws
Standard IGF-1 IGF-1 LR3's reduced IGFBP binding makes it the preferred choice for in vitro research where consistent, predictable growth factor exposure is required
Glucose Control's evidence rests largely on a single proof-of-concept 2020 clinical trial published in BMJ Open Diabetes Research & Care
AOD 9604 10mg was easy to verify against the listed batch information
US$ 28.73
US$ 25.07
US$ 26.61
US$ 25.24
